.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Fuji
Merck
Cerilliant
Medtronic
Colorcon
Cipla
Accenture
Chinese Patent Office
Dow

Generated: June 26, 2017

DrugPatentWatch Database Preview

Lisinopril - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lisinopril and what is the scope of lisinopril freedom to operate?

Lisinopril
is the generic ingredient in four branded drugs marketed by Silvergate Pharms, Apotex Inc, Wockhardt, Sandoz, Invagen Pharms, Lupin, Aurobindo, Prinston Inc, Sun Pharm Inds Ltd, Ivax Sub Teva Pharms, Accord Hlthcare, Merck, Watson Labs, Hikma Intl Pharms, Mylan, Alvogen Malta, and Teva, and is included in twenty-one NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lisinopril has one patent family member in one country.

There are twenty-one drug master file entries for lisinopril. Eighty suppliers are listed for this compound.

Summary for Generic Name: lisinopril

Tradenames:4
Patents:3
Applicants:17
NDAs:21
Drug Master File Entries: see list21
Suppliers / Packagers: see list80
Bulk Api Vendors: see list42
Clinical Trials: see list92
Patent Applications: see list6,859
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:lisinopril at DailyMed

Pharmacology for Ingredient: lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
LISINOPRIL
lisinopril
TABLET;ORAL076059-003Jul 1, 2002ABRXNoNo► Subscribe► Subscribe
Aurobindo
LISINOPRIL
lisinopril
TABLET;ORAL077622-001Feb 22, 2006ABRXNoNo► Subscribe► Subscribe
Prinston Inc
LISINOPRIL
lisinopril
TABLET;ORAL075743-006Jul 1, 2002ABRXNoNo► Subscribe► Subscribe
Lupin
LISINOPRIL
lisinopril
TABLET;ORAL077321-004Sep 9, 2005ABRXNoNo► Subscribe► Subscribe
Teva
LISINOPRIL
lisinopril
TABLET;ORAL075783-002Jul 1, 2002DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
PRINIVIL
lisinopril
TABLET;ORAL019558-003Dec 29, 19874,374,829*PED► Subscribe
Alvogen Malta
ZESTRIL
lisinopril
TABLET;ORAL019777-004May 19, 19884,374,829*PED► Subscribe
Alvogen Malta
ZESTRIL
lisinopril
TABLET;ORAL019777-005Apr 29, 19934,374,829*PED► Subscribe
Merck
PRINIVIL
lisinopril
TABLET;ORAL019558-006Jan 28, 19944,374,829*PED► Subscribe
Merck
PRINIVIL
lisinopril
TABLET;ORAL019558-002Dec 29, 19874,374,829*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lisinopril

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2017075368► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Cipla
Teva
Medtronic
Chubb
AstraZeneca
UBS
Harvard Business School
Covington
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot